Phase II Immunogenicity and Tolerability Studies
Phase II Immunogenicity and Tolerability Studies Designing Phase II Vaccine Studies for Immunogenicity & Tolerability What Phase II Vaccine Trials Are Designed to Demonstrate Phase II vaccine trials expand first-in-human learnings to a larger and more diverse population (often a few hundred participants) with two primary aims: (1) quantify immunogenicity with sufficient precision to compare…
Read More “Phase II Immunogenicity and Tolerability Studies” »